User profiles for Clark D Russell
 | Clark D. RussellClinical Lecturer in Infectious Diseases, University of Edinburgh Verified email at ed.ac.uk Cited by 13193 |
[HTML][HTML] Genetic mechanisms of critical illness in COVID-19
, … . 45 Hope D. 45 McCulloch C. 45 McQuillan L. 45 Clark … - Nature, 2021 - nature.com
Host-mediated lung inflammation is present 1 , and drives mortality 2 , in the critical illness
caused by coronavirus disease 2019 (COVID-19). Host genetic variants associated with …
caused by coronavirus disease 2019 (COVID-19). Host genetic variants associated with …
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
Objective To characterise the clinical features of patients admitted to hospital with coronavirus
disease 2019 (covid-19) in the United Kingdom during the growth phase of the first wave …
disease 2019 (covid-19) in the United Kingdom during the growth phase of the first wave …
[PDF][PDF] SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses
…, N Price, A Rambaut, DL Robertson, CD Russell… - Cell, 2022 - cell.com
On 24 th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529
was announced, containing far more mutations in Spike (S) than previously reported …
was announced, containing far more mutations in Spike (S) than previously reported …
[HTML][HTML] Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
The 2019 novel coronavirus (2019-nCoV) outbreak is a major challenge for clinicians. The
clinical course of patients remains to be fully characterised, little data are available that …
clinical course of patients remains to be fully characterised, little data are available that …
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C …
Objective To develop and validate a pragmatic risk score to predict mortality in patients admitted
to hospital with coronavirus disease 2019 (covid-19). Design Prospective observational …
to hospital with coronavirus disease 2019 (covid-19). Design Prospective observational …
[HTML][HTML] Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP …
Background Microbiological characterisation of co-infections and secondary infections in
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …
[HTML][HTML] Comorbidities, multimorbidity and COVID-19
The influence of comorbidities on COVID-19 outcomes has been recognized since the earliest
days of the pandemic. But establishing causality and determining underlying mechanisms …
days of the pandemic. But establishing causality and determining underlying mechanisms …
[HTML][HTML] Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation …
…, M Cevik, A Casey, P Bannister, CD Russell… - The Lancet Regional …, 2021 - thelancet.com
Background This study sought to establish the long-term effects of Covid-19 following
hospitalisation. Methods 327 hospitalised participants, with SARS-CoV-2 infection were recruited …
hospitalisation. Methods 327 hospitalised participants, with SARS-CoV-2 infection were recruited …
Tissue-specific immunopathology in fatal COVID-19
Rationale: In life-threatening coronavirus disease (COVID-19), corticosteroids reduce mortality,
suggesting that immune responses have a causal role in death. Whether this deleterious …
suggesting that immune responses have a causal role in death. Whether this deleterious …
[HTML][HTML] SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses
We examined clinical outcomes of co-infection with influenza viruses, respiratory syncytial
virus, or adenoviruses in 212 466 adults with SARS-CoV-2 infection who were admitted to …
virus, or adenoviruses in 212 466 adults with SARS-CoV-2 infection who were admitted to …